UNSPSC 51294420: Oxypertine hydrochloride

This classification denotes a dopamine antagonist C23H29N3O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9P131473P6, chemically known as 1h-indole, 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)-, hydrochloride (1:1), but more generally known as oxypertine hydrochloride, which bears US NIH Compound Identifier 24194514. European Medicines Agency schedules Oxypertine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03592MIG.

Most nations, for tariff and trade purposes, schedule oxypertine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, OXYPERTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1C(C2CC(C(CC2[NH]1)OC)OC)CCN3CCN(CC3)C4CCCCC4.CL.

UNSPSC 51294420 Oxypertine hydrochloride is a Commodity code that does not align with recent state and local procurement activity in the available record. The single recent opportunity tagged under this code — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 — solicits naloxone and drug deactivation systems, not oxypertine hydrochloride. Naloxone is an opioid antagonist used in emergency overdose response; oxypertine is a distinct pharmaceutical with a different therapeutic profile and use case. The mismatch suggests either a cataloging error in the state and local procurement system or a data artifact in the opportunity tagging.

Without recent state and local opportunities actually procuring oxypertine hydrochloride under this code, no reliable geographic spread, issuing-body pattern, or market signal is available to assess pursuit merit or current activity level.